<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="humans [26]. The drugs included in the SOLIDARITY trial are" exact="lopinavir" post="and ritonavirplus interferon beta as well as chloroquine, and"/>
 <result pre="have shown positive responses to treatments with a combination of" exact="lopinavir" post="and ritonavir [2]. Remdesivir has shown high efficacy against"/>
 <result pre="positive responses to treatments with a combination of lopinavir and" exact="ritonavir" post="[2]. Remdesivir has shown high efficacy against other coronaviruses"/>
 <result pre="include immunoglobulins, remdesivir, arbidol hydrochloride combined with interferon atomisation, hydroxychloroquine," exact="ritonavir" post="plus oseltamivir and many more [2]. Hydroxychloroquine, an anti-malarial"/>
 <result pre="of 80 individuals showed improvement in symptoms upon administration of" exact="hydroxychloroquine" post="and azithromycin [48]. However, there are still no convincing"/>
 <result pre="individuals showed improvement in symptoms upon administration of hydroxychloroquine and" exact="azithromycin" post="[48]. However, there are still no convincing studies to"/>
 <result pre="[48]. However, there are still no convincing studies to establish" exact="hydroxychloroquine" post="as the therapeutic candidate for SARS-CoV-2 and further investigations"/>
 <result pre="Epidemiol.202011010.1093/ije/dyaa03331828333 48.GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.SevestreJ.MailheM.DoudierB.AubryC.AmraneS.et al.Clinical and microbiological effect of a combination of" exact="hydroxychloroquine" post="and azithromycin in 80 COVID-19 patients with at least"/>
 <result pre="al.Clinical and microbiological effect of a combination of hydroxychloroquine and" exact="azithromycin" post="in 80 COVID-19 patients with at least a six-day"/>
</results>
